Immunotherapy With Leukemia-cell-derived Heat Shock Protein 70 Triggers Induction Of Leukemia-specific Antibodies
Main Category: Cancer / OncologyAlso Included In: Lymphoma / Leukemia / Myeloma; Clinical Trials / Drug Trials
Article Date: 24 Jul 2008 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Even after chemotherapies and stem cell transplants, relapses still occur in leukemia patients. This study established a mouse model after bone marrow transplant and found that the immunization of mice with leukemia-cell-derived heat shock protein 70 (HSP) induced leukemia-specific immunities and prolonged their survival.
The tumor-derived-HSP binds the tumor-specific antigenic peptides, making it an effective cancer vaccination. It has reported that patients with peptide-specific antibodies survived longer than those without.
Using leukemia-specific antibodies induced by HSP-based vaccination would be useful for the prognosis of leukemia and facilitate the establishment of novel therapeutic strategies in the future.
"Induction of leukemia-specific anti-bodies by immunotherapy with leukemia-cell-derived heat shock protein 70"
Junko Jimbo, Kazuya Sato, Takaaki Hosoki, Motohiro Shindo, Katsuya Ikuta, Yoshihiro Torimoto, Yutaka Kohgo
Cancer Science - Volume 99 Issue 7, Pages 1427 - 1434
10.1111/j.1349-7006.2008.00829.x
Click here to view Abstract online
About Cancer Science
Cancer Science (formerly Japanese Journal of Cancer Research) aims to present research that has a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal publishes original articles and editorials, letters to the editor, review articles and reports describing original research in the fields of basic, translational and clinical cancer.
Subject categories include:
-- carcinogenesis
-- tumor biology and pathology
-- molecular biology and genetics
-- epidemiology and prevention
-- immunology and virology
-- experimental therapeutics
-- clinical medicine
www.blackwellpublishing.com/journal.asp?ref=1347-9032&site=1
Visit our cancer / oncology section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/115938.php>
APA
http://www.medicalnewstoday.com/releases/115938.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




